Sanne E. de Jong

Sanne E. de Jong

Auto-generated profile, based on publicly available information

Sanne E. de Jong

Leiden Immunoparasitology Group, Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Cell Host & Microbe
Verified
Journal Article
Closed access
SJSanne E. de Jong
Sanne E. de Jong
AOAxel Olin
Axel Olin
BPBali Pulendran
Bali Pulendran

19 October 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MMMoustapha Mbow
Moustapha Mbow
BLBridget M. Larkin
Bridget M. Larkin
LMLynn Meurs
Lynn Meurs
LWLinda J. Wammes
Linda J. Wammes
SJSanne E. de Jong
Sanne E. de Jong
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh
Background. Schistosome infections are often clinically silent, but some individuals develop severe pathological reactions. In several disease processes, T-helper 17 (Th17) cells have been linked to tissue injuries, while regulatory T cells (Tregs) are thought to downmodulate inflammatory reactions. We assessed whether bladder pathology in human Schistosoma haematobium infection is related to the balance of Th17 cells and Tregs. We used a murine model of Schistosoma mansoni infection to further investigate whether the peripheral profiles reflected ongoing events in tissues. Methods. We characterized T-helper cell subsets in the peripheral blood of children residing in a S. haematobium–endemic area and in the peripheral blood, spleen, and hepatic granulomas of S. mansoni–infected high-pathology CBA mice and low-pathology C57BL/6 mice. Results. S. haematobium–infected children with bladder pathology had a significantly higher percentage of Th17 cells than those without pathology. Moreover, the Th17/Treg ratios were significantly higher in infected children with pathology, compared with infected children without pathology. Percentages of interleukin 17–producing cells were significantly higher in spleen and granulomas of CBA mice, compared with C57BL/6 mice. This difference was also reflected in the peripheral blood. Conclusions. This is the first study to indicate that Th17 cells may be involved in the pathogenesis of human schistosomiasis.

1 April 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
MSMaurice H. J. Selman
Maurice H. J. Selman
SJSanne E. de Jong
Sanne E. de Jong
DSDarius Soonawala
Darius Soonawala
FKFrank P. Kroon
Frank P. Kroon
AAAyola Akim Adegnika
Ayola Akim Adegnika
MWManfred Wuhrer
Manfred Wuhrer
Antibody effector functions have been shown to be influenced by the structure of the Fc N-glycans. Here we studied the changes in plasma or serum IgG Fc N-glycosylation upon vaccination of 10 Caucasian adults and 10 African children. Serum/plasma IgG was purified by affinity chromatography prior to and at two time points after vaccination. Fc N-glycosylation profiles of individual IgG subclasses were determined for both total IgG and affinity-purified anti-vaccine IgG using a recently developed fast nanoliquid chromatography-electrospray ionization MS (LC-ESI-MS) method. While vaccination had no effect on the glycosylation of total IgG, anti-vaccine IgG showed increased levels of galactosylation and sialylation upon active immunization. Interestingly, the number of sialic acids per galactose increased during the vaccination time course, suggesting a distinct regulation of galactosylation and sialylation. In addition we observed a decrease in the level of IgG1 bisecting N-acetylglucosamine whereas no significant changes were observed for the level of fucosylation. Our data indicate that dependent on the vaccination time point the infectious agent will encounter IgGs with different glycosylation profiles, which are expected to influence the antibody effector functions relevant in immunity.

16 June 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SJSanne E. de Jong
Sanne E. de Jong
MSMaurice H. J. Selman
Maurice H. J. Selman
AAAyola A. Adegnika
Ayola A. Adegnika
AAAbena S. Amoah
Abena S. Amoah
ERElly van Riet
Elly van Riet
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh
Immunoglobulin G (IgG) Fc N-glycosylation affects antibody-mediated effector functions and varies with inflammation rooted in both communicable and non-communicable diseases. Worldwide, communicable and non-communicable diseases tend to segregate geographically. Therefore, we studied whether IgG Fc N-glycosylation varies in populations with different environmental exposures in different parts of the world. IgG Fc N-glycosylation was analysed in serum/plasma of 700 school-age children from different communities of Gabon, Ghana, Ecuador, the Netherlands and Germany. IgG1 galactosylation levels were generally higher in more affluent countries and in more urban communities. High IgG1 galactosylation levels correlated with low total IgE levels, low C-reactive protein levels and low prevalence of parasitic infections. Linear mixed modelling showed that only positivity for parasitic infections was a significant predictor of reduced IgG1 galactosylation levels. That IgG1 galactosylation is a predictor of immune activation is supported by the observation that asthmatic children seemed to have reduced IgG1 galactosylation levels as well. This indicates that IgG1 galactosylation levels could be used as a biomarker for immune activation of populations, providing a valuable tool for studies examining the epidemiological transition from communicable to non-communicable diseases.

17 October 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LWLinda J. Wammes
Linda J. Wammes
FHFirdaus Hamid
Firdaus Hamid
AWAprilianto Eddy Wiria
Aprilianto Eddy Wiria
LMLinda May
Linda May
MKMaria Mardalena Martini Kaisar
Maria Mardalena Martini Kaisar
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh
In cross-sectional studies, chronic helminth infections have been associated with immunological hyporesponsiveness that can affect responses to unrelated antigens. To study the immunological effects of deworming, we conducted a cluster-randomized, double-blind, placebo-controlled trial in Indonesia and assigned 954 households to receive albendazole or placebo once every 3 mo for 2 y. Helminth-specific and nonspecific whole-blood cytokine responses were assessed in 1,059 subjects of all ages, whereas phenotyping of regulatory molecules was undertaken in 121 school-aged children. All measurements were performed before and at 9 and 21 mo after initiation of treatment. Anthelmintic treatment resulted in significant increases in proinflammatory cytokine responses to Plasmodium falciparum-infected red blood cells (PfRBCs) and mitogen, with the largest effect on TNF responses to PfRBCs at 9 mo—estimate [95% confidence interval], 0.37 [0.21–0.53], P value over time (Ptime) < 0.0001. Although the frequency of regulatory T cells did not change after treatment, there was a significant decline in the expression of the inhibitory molecule cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) on CD4+ T cells of albendazole-treated individuals, –0.060 [–0.107 to –0.013] and –0.057 [–0.105 to –0.008] at 9 and 21 mo, respectively; Ptime = 0.017. This trial shows the capacity of helminths to up-regulate inhibitory molecules and to suppress proinflammatory immune responses in humans. This could help to explain the inferior immunological responses to vaccines and lower prevalence of inflammatory diseases in low- compared with high-income countries. Significance Chronic helminth infections are accompanied by profound immune regulation. In humans, helminth-induced immune reactivity has not been thoroughly investigated in trial settings. We assessed the effect of anthelmintic treatment on immune responses in a whole community in a placebo-controlled randomized controlled trial. We show increased immune responses to helminth-specific as well as unrelated antigens, in parallel with decreased expression of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), which is a molecule involved in putting the brake on immune activation. Deworming seems to lead to decreased immunoregulation and increased immune responsiveness. These findings are of importance regarding the suboptimal vaccine responses in helminth-endemic areas and also in anticipating the future rise in inflammatory diseases when helminth infections are increasingly controlled.

22 April 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SJSanne E. de Jong
Sanne E. de Jong
VUVincent van Unen
Vincent van Unen
MMMikhael D. Manurung
Mikhael D. Manurung
KSKoen A. Stam
Koen A. Stam
JGJelle J. Goeman
Jelle J. Goeman
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh